Início
Mercados
Gráficos e ideias
Algo
Notícias
Store
Corretoras
Baixar
Calendário econômico
Sinais de Negociação
Terminal web
Pressione
/
para pesquisar: @user, $symbol, ...
Pesquisar
Login
Criar uma conta
Português
English
Русский
中文
Español
日本語
Deutsch
한국어
Français
Italiano
Türkçe
WGS
#1574
GeneDx Holdings Corp. Class A Common Stock
79.7
1
+0.35%
Setor:
Base:
Moeda do lucro:
Faixa diária
Faixa anual
Mudança diária
+0.35%
Mudança mensal
-16.98%
Mudança em 6 meses
-37.42%
Mudança anual
-21.08%
Fechamento anterior
79.4
3
Open
79.7
1
Bid
Ask
Low
79.7
1
High
79.7
1
Volume
69
Mercados
Ações
Cuidados de saúde
WGS
Open full chart
Financials
Overview
Relatórios
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
1.34 M
7.42 M
11.77 M
26.05 M
28.07 M
29.29 M
—
Valuation ratios
Enterprise value
—
—
—
-30.9 M
2.07 B
3.7 B
11.73 B
Price to earnings ratio
—
—
—
-0.37
-39.62
-178.16
2 056.29
Price to sales ratio
—
—
—
0.32
6.77
8.71
30.64
Price to cash flow ratio
—
—
—
-0.36
-72.53
111.94
-532.38
Price to book ratio
—
—
—
0.28
8.43
12.09
20.21
Enterprise value to EBITDA ratio
—
—
—
0.19
-135.39
3 125.99
3 265.68
Profitability ratios
Return on assets %
—
0.44
1.12
0.42
0.12
0.04
0.05
Return on equity %
—
0.63
2.16
0.77
0.21
0.07
0.08
Return on invested capital %
—
648.97
1 177.56
226.39
36.94
18.96
21.28
Gross margin %
—
7.82
11.4
44.19
63.64
69.74
278.22
Operating margin %
—
210.25
284.48
88.67
7.6
3.06
13.69
EBITDA margin %
—
-197.31
-269.16
-78.25
-5.01
0.28
-6.97
Net margin %
—
115.64
233.91
86.3
17.12
4.92
21.29
Liquidity ratios
Quick ratio
—
4.44
1.38
2.95
3.42
2.34
10.69
Current ratio
14.12
4.77
1.47
3.1
3.61
2.46
11.29
Inventory turnover
—
6.84
11.1
10.03
11.43
10.52
10.9
Asset turnover
—
0.43
0.45
0.45
0.73
0.91
0.91
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
—
0.02
0.01
0.13
0.12
0.09
0.42
Long term debt to total equity ratio
—
0.03
0.02
0.23
0.21
0.16
0.72
Per share metrics
Operating cash flow per share
—
58.15
31.18
7.41
1.06
1.16
1.15
EBIT per share
—
-134.5
-67.5
-7.37
-0.86
-0.29
-0.68
EBITDA per share
—
-127.84
-61.71
-6.56
-0.57
0.04
-0.35
Total debt per share
—
—
—
—
—
—
—
Cash per share
—
122.32
12.1
5.35
5.25
5.98
21.54
Net current asset value per share
—
147.64
20.77
7.5
7.36
9.37
32.52
Tangible book value per share
—
118.5
6.55
2.28
3.22
4.41
14.69
Working capital per share
—
116.72
6.67
5.08
5.32
5.56
20.81
Book value per share
—
118.5
24.78
9.38
9.12
10.76
39.37
Notícias
GeneDx: The Growth Story Isn't Dead, It's Changing (Rating Upgrade) (NASDAQ:WGS)
These Analysts Slash Their Forecasts On GeneDx After Q4 Results - GeneDx Holdings (NASDAQ:WGS)
BTIG reduz preço-alvo da GeneDx devido a perspectiva de crescimento concentrado no segundo semestre
BTIG cuts GeneDx stock price target on back-end loaded growth outlook
GeneDx Holdings Corp. 2025 Q4 - Results - Earnings Call Presentation (NASDAQ:WGS) 2026-02-23
GeneDx Holdings Corp. (WGS) Q4 2025 Earnings Call Transcript
GeneDx registra crescimento de 54% na receita e planeja expansão agressiva em 2026
GeneDx Q4 2025 slides: 54% revenue growth, aggressive 2026 expansion
Canaccord Genuity reitera recomendação de compra para GeneDx com preço-alvo de US$ 170
TD Cowen mantém recomendação de compra para ações da GeneDx antes de divulgação de resultados
GeneDx stock maintained at Buy by TD Cowen ahead of results call
Canaccord Genuity reiterates Buy on GeneDx stock, keeps $170 target